{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:06:49Z","timestamp":1794442009450,"version":"4.9.1"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/12\/2020\/NCD-III"],"award-info":[{"award-number":["5\/13\/12\/2020\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/79\/2020\/NCD-III"],"award-info":[{"award-number":["5\/13\/79\/2020\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejmech.2023.115927","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:37:39Z","timestamp":1699659459000},"page":"115927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Synthetic product-based approach toward potential antileishmanial drug development"],"prefix":"10.1016","volume":"263","author":[{"given":"Rohit","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Teli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-5304","authenticated-orcid":false,"given":"Md Jawaid","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1978-6029","authenticated-orcid":false,"given":"Gurubasavaraja Swamy Purawarga","family":"Matada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115927_bib1","series-title":"Discovery and development of therapeutics from natural products against neglected tropical diseases","first-page":"293","article-title":"Leishmaniasis control: limitations of current drugs and prospects of natural products","author":"Tiwari","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115927_bib2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cmdc.202100022","article-title":"A \u201cGolden Age\u201d for the discovery of new antileishmanial agents: current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system","volume":"16","author":"Rosa","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115927_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1998.58.436","article-title":"Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain","volume":"58","author":"Lopez-Velez","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2023.115927_bib4","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1002\/chem.202000045","article-title":"A gold (i) complex containing an oleanolic acid derivative as a potential anti\u2010ovarian\u2010cancer agent by inhibiting trxr and activating ros\u2010mediated ers","volume":"26","author":"Bian","year":"2020","journal-title":"Chem.--Eur. J."},{"key":"10.1016\/j.ejmech.2023.115927_bib5","series-title":"Leishmaniasis-fact Sheet","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.ejmech.2023.115927_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115609","article-title":"The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis","author":"Pal","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib7","series-title":"An Overview of Leishmaniasis: Historic to Future Perspectives, Vectors and Vector-Borne Zoonotic Diseases","author":"G\u00fcran","year":"2018"},{"key":"10.1016\/j.ejmech.2023.115927_bib8","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115927_bib9","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/molecules25102281","article-title":"Virtual screening and the in vitro assessment of the antileishmanial activity of lignans","volume":"25","author":"dos Santos Maia","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115927_bib10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/pathogens11080950","article-title":"Development of novel anti-leishmanials: the case for structure-based approaches","volume":"11","author":"Soni","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2023.115927_bib11","series-title":"Sur la leishmanioses t\u00e9gumentaires: classification g\u00e9n\u00e9rale des leishmanioses","author":"da Matta","year":"1916"},{"key":"10.1016\/j.ejmech.2023.115927_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132808","article-title":"An insight into the recent developments in anti-infective potential of indole and associated hybrids","author":"Mathada","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115927_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/092986707780362862","article-title":"Chemotherapy of leishmaniasis: past, present and future","volume":"14","author":"Mishra","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib14","first-page":"1561","article-title":"The wellcome trust illustrated history of tropical diseases","volume":"314","author":"Cox","year":"1997","journal-title":"BMJ-Br. Med. J.-Int. Ed."},{"key":"10.1016\/j.ejmech.2023.115927_bib15","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/slct.202100115","article-title":"Quinoline: a promising scaffold in recent antiprotozoal drug discovery","volume":"6","author":"Dorababu","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115927_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130369","article-title":"Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: an updated review","volume":"1237","author":"Singh","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115927_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/1570159X19666210803144815","article-title":"Overview of chemistry and therapeutic potential of non-nitrogen heterocyclics as anticonvulsant agents","volume":"20","author":"Pal","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2023.115927_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301200","article-title":"Nitrogen\u2010containing heterocyclic scaffolds as EGFR inhibitors: design approaches, molecular docking, and structure\u2010activity relationships","volume":"8","author":"Pal","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115927_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11030-019-09953-4","article-title":"Insights into the current status of privileged N-heterocycles as antileishmanial agents","volume":"24","author":"Razzaghi-Asl","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2023.115927_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136021","article-title":"Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors","author":"Pal","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115927_bib21","article-title":"Search for structurally diverse heterocyclic analogs as dual-acting antimalarial and antileishmanial agents: an overview","author":"Dey","year":"2022","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.ejmech.2023.115927_bib22","article-title":"Synthetic and medicinal perspective of antileishmanial agents: an overview","author":"Pawar","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115927_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/ph15020148","article-title":"Evolution of acridines and xanthenes as a core structure for the development of antileishmanial agents","volume":"15","author":"Silva","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115927_bib24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/chir.23494","article-title":"A recent update on new synthetic chiral compounds with antileishmanial activity","volume":"34","author":"Verboni","year":"2022","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2023.115927_bib25","series-title":"Biomaterials and bionanotechnology","first-page":"263","article-title":"Novel therapeutic approaches for the treatment of leishmaniasis","author":"Soni","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115927_bib26","doi-asserted-by":"crossref","DOI":"10.1017\/pao.2018.1","article-title":"Slow pace of antileishmanial drug development","volume":"4","author":"Kumar","year":"2018","journal-title":"Parasitol Open"},{"key":"10.1016\/j.ejmech.2023.115927_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","article-title":"Paromomycin","volume":"103","author":"Davidson","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2023.115927_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113606","article-title":"Recent advancements in anti-leishmanial research: synthetic strategies and structural activity relationships","volume":"223","author":"Gupta","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115927_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/10611869808997874","article-title":"Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice","volume":"5","author":"Paul","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejmech.2023.115927_bib31","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.3390\/microorganisms9122500","article-title":"Antileishmanial drug discovery and development: time to reset the model?","volume":"9","author":"Ol\u00edas-Molero","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2023.115927_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0166-6851(88)90166-1","article-title":"Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes","volume":"31","author":"Beach","year":"1988","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115927_bib33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/978-1-4613-1575-9_111","article-title":"Effects of a squalene-2, 3-epoxidase inhibitor on propagation and sterol biosynthesis of Leishmania promastigotes and amastigotes","author":"Beach","year":"1989","journal-title":"Leishmaniasis, Springer"},{"key":"10.1016\/j.ejmech.2023.115927_bib34","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C0MB00307G","article-title":"RJ 860 ward, RK arni, AH oliveira, MT 861 murakami","volume":"7","author":"Souza","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2023.115927_bib35","doi-asserted-by":"crossref","first-page":"e1297","DOI":"10.1371\/journal.pntd.0001297","article-title":"The susceptibility of trypanosomatid pathogens to PI3\/mTOR kinase inhibitors affords a new opportunity for drug repurposing","volume":"5","author":"Diaz-Gonzalez","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115927_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2023.115927_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001987","article-title":"Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection","volume":"6","author":"Mukherjee","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115927_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj2860009","article-title":"Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures","volume":"286","author":"Benson","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.115927_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2023.115927_bib40","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2013current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2023.115927_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1472-8206.2003.00168.x","article-title":"Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients","volume":"17","author":"Minodier","year":"2003","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115927_bib42","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4155\/fmc.13.143","article-title":"Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives","volume":"5","author":"Yasinzai","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0924-8579(03)00211-5","article-title":"Leishmaniasis: efflux pumps and chemoresistance","volume":"22","author":"Leandro","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2023.115927_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0166-6851(94)00156-1","article-title":"The P-glycoprotein-related gene family in Leishmania","volume":"68","author":"L\u00e9gar\u00e9","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115927_bib45","first-page":"2011","article-title":"Antimony resistance in Leishmania, focusing on experimental research","author":"Jeddi","year":"2011","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.ejmech.2023.115927_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1051\/parasite\/1998052167","article-title":"Development and characterization of paromomycin-resistant Leishmania donovani promastigotes","volume":"5","author":"Maarouf","year":"1998","journal-title":"Parasite"},{"key":"10.1016\/j.ejmech.2023.115927_bib47","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.46.12.3731-3738.2002","article-title":"Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion","volume":"46","author":"Basselin","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115927_bib48","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.115927_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of amphotericin B resistance in Leishmania donovani promastigotes","volume":"42","author":"Mbongo","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115927_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2023.115927_bib51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/JIR.S262132","article-title":"Recent updates on anti-inflammatory and antimicrobial effects of furan natural derivatives","author":"Alizadeh","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejmech.2023.115927_bib52","doi-asserted-by":"crossref","DOI":"10.1021\/j150469a016","article-title":"Encyclopedia of chemical technology. Vol. II","volume":"53","author":"Kirk","year":"1949","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200023","article-title":"Synthesis, in vitro antileishmanial efficacy and hit\/lead identification of nitrofurantoin\u2010triazole hybrids","volume":"17","author":"Zuma","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115927_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115012","article-title":"Synthesis and in vitro antileishmanial activity of alkylene-linked nitrofurantoin-triazole hybrids","volume":"246","author":"Zuma","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ddr.21755","article-title":"Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide","volume":"82","author":"Kannigadu","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2023.115927_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cbdd.14097","article-title":"Exploring novel nitrofuranyl sulfonohydrazides as anti\u2010Leishmania and anti\u2010cancer agents: synthesis, in vitro efficacy and hit identification","volume":"100","author":"Kannigadu","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115927_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106242","article-title":"Probing O-substituted nifuroxazide analogues against Leishmania: synthesis, in vitro efficacy, and hit\/lead identification","volume":"176","author":"Badenhorst","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.115927_bib58","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/ph15091058","article-title":"Design, rational repurposing, synthesis, in vitro evaluation, homology modeling and in silico study of sulfuretin analogs as potential antileishmanial hit compounds","volume":"15","author":"Hassan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115927_bib59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejmech.2015.06.009","article-title":"Living on pyrrolic foundations\u2013Advances in natural and artificial bioactive pyrrole derivatives","volume":"100","author":"Domagala","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113458","article-title":"Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo [1, 2-b] isoquinolines as antileishmanial agents","volume":"220","author":"Barbolla","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib61","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1080\/14756366.2021.1969385","article-title":"Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards development of potential treatment of Leishmania donovani","volume":"36","author":"Hassan","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib62","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.3390\/molecules26113166","article-title":"Thiazole ring\u2014a biologically active scaffold","volume":"26","author":"Petrou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115927_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127616","article-title":"Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds","volume":"30","author":"Schadich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115927_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/2211352517666190527112955","article-title":"Synthesis and biological activity of some aminothiazole derivatives as antileishmanial agents","volume":"18","author":"Rezaei","year":"2020","journal-title":"Anti-Infect. Agent."},{"key":"10.1016\/j.ejmech.2023.115927_bib65","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jgar.2020.02.028","article-title":"Study of in vitro biological activity of thiazoles on Leishmania (Leishmania) infantum","volume":"22","author":"de Oliveira","year":"2020","journal-title":"J. Glob. Antimicrob.l Resist."},{"key":"10.1016\/j.ejmech.2023.115927_bib66","first-page":"83","article-title":"A review on heterocyclic: synthesis and their application in medicinal chemistry of imidazole moiety","volume":"6","author":"Hossain","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115927_bib67","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1080\/07391102.2020.1845979","article-title":"Thiohydantoins as anti-leishmanial agents: n vitro biological evaluation and multi-target investigation by molecular docking studies","volume":"40","author":"Camargo","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115927_bib68","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/acsinfecdis.0c00855","article-title":"Synthesis and antileishmanial evaluation of arylimidamide\u2013azole hybrids containing a phenoxyalkyl linker","volume":"7","author":"Abdelhameed","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115927_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112914","article-title":"Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: in vitro and in vivo appraisal","volume":"209","author":"Thompson","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112956","article-title":"In vitro identification of imidazo [1, 2-a] pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition","volume":"210","author":"Bazin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib71","doi-asserted-by":"crossref","first-page":"38328","DOI":"10.1039\/D0RA07881F","article-title":"Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues","volume":"10","author":"Nandikolla","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115927_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00583-22","article-title":"Antileishmanial activities of (Z)-2-(Nitroimidazolylmethylene)-3 (2H)-Benzofuranones: synthesis, in vitro assessment, and bioactivation by NTR 1 and 2","volume":"66","author":"Navidpour","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115927_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105230","article-title":"Voltage gated sodium channel inhibitors as anticonvulsant drugs: a systematic review on recent developments and structure activity relationship studies","volume":"115","author":"Pal","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/C6NJ03181A","article-title":"Biologically active pyrazole derivatives","volume":"41","author":"Ansari","year":"2017","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib75","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115927_bib76","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1080\/14756366.2022.2117316","article-title":"New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations","volume":"37","author":"Bekhit","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib77","first-page":"6225","article-title":"Novel dual acting antimalarial antileishmanial agents derived from pyrazole moiety","volume":"12","author":"Bekhit","year":"2022","journal-title":"Biointerface Res. Appl. Chem"},{"key":"10.1016\/j.ejmech.2023.115927_bib78","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.3390\/molecules27175401","article-title":"Synthesis, structure and antileishmanial evaluation of endoperoxide\u2013pyrazole hybrids","volume":"27","author":"Amado","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115927_bib79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejmech.2013.02.038","article-title":"Potent naphthoquinones against antimony-sensitive and-resistant Leishmania parasites: synthesis of novel \u03b1-and nor-\u03b1-lapachone-based 1, 2, 3-triazoles by copper-catalyzed azide\u2013alkyne cycloaddition","volume":"63","author":"Guimar\u00e3es","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2019.01.047","article-title":"Triazole derivatives and their antiplasmodial and antimalarial activities","volume":"166","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib82","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4155\/fmc-2021-0354","article-title":"Design, synthesis and evaluation of novel phenanthridine triazole analogs as potential antileishmanial agents","volume":"14","author":"Nandikolla","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2021.100105","article-title":"1, 2, 3-triazole derivative: synthesis, characterization, DFT, molecular docking study and antibacterial-antileishmanial activities","volume":"98","author":"Celik","year":"2021","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115927_bib84","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1021\/acs.jmedchem.1c00206","article-title":"Efficient dimerization disruption of leishmania infantum trypanothione reductase by triazole-phenyl-thiazoles","volume":"64","author":"Revuelto","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111857","article-title":"Synthesis and biological activity of novel 4-aminoquinoline\/1, 2, 3-triazole hybrids against Leishmania amazonensis","volume":"141","author":"Glanzmann","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.115927_bib86","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00044-020-02553-0","article-title":"Synthesis and in vitro antimycobacterial and antileishmanial activities of hydroquinone-triazole hybrids","volume":"29","author":"Horn","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115927_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104437","article-title":"Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl) ethyl]-1H-1, 2, 3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: in silico ADMET, in vitro activity, docking and molecular dynamic simulations","volume":"105","author":"Holanda","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104122","article-title":"Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids","volume":"103","author":"Pertino","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib89","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00436-022-07431-9","article-title":"Functionalized 1, 2, 3-triazolium salts as potential agents against visceral leishmaniasis","volume":"121","author":"das Chagas Almeida","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2023.115927_bib90","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1021\/acs.jmedchem.1c00725","article-title":"Nitric oxide induction in peritoneal macrophages by a 1, 2, 3-triazole derivative improves its efficacy upon leishmania amazonensis in vitro infection","volume":"64","author":"Almeida-Souza","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-022-00903-0","article-title":"Synthesis, antimalarial, antileishmanial evaluation, and molecular docking study of some 3-aryl-2-styryl substituted-4 (3H)-quinazolinone derivatives","volume":"16","author":"Seifu","year":"2022","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib92","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/D1MD00336D","article-title":"Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies","volume":"13","author":"Kumari","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/cbdd.13790","article-title":"Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives","volume":"97","author":"Prinsloo","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115927_bib94","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","article-title":"A review on anticancer potential of bioactive heterocycle quinoline","volume":"97","author":"Afzal","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115973","article-title":"A comprehensive review on the biological interest of quinoline and its derivatives","volume":"32","author":"Matada","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib96","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1021\/acs.jmedchem.1c00813","article-title":"Amino-substituted 3-Aryl-and 3-heteroarylquinolines as potential antileishmanial agents","volume":"64","author":"Hammill","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib97","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.3390\/molecules27227892","article-title":"Synthesis and anti-leishmanial properties of quinolones derived from zanthosimuline","volume":"27","author":"J\u00e9z\u00e9quel","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115927_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115511","article-title":"Cytotoxicity of 4-substituted quinoline derivatives: anticancer and antileishmanial potential","volume":"28","author":"Costa","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib99","first-page":"712","article-title":"Synthesis, in silico study and antileishmanial evaluation of new selenides derived from 7-Chloro-quinoline and N-phenylacetamides","volume":"32","author":"Huang","year":"2021","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115927_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200109","article-title":"A Core-Linker-Polyamine (CLP) Strategy enables rapid discovery of antileishmanial aminoalkylquinolinecarboxamides that target oxidative stress mechanism","volume":"17","author":"Shah","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115927_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2023.2187634","article-title":"An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)","author":"Pal","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115927_bib102","first-page":"2014","article-title":"Significance and biological importance of pyrimidine in the microbial world","author":"Sharma","year":"2014","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib103","article-title":"Design, synthesis, in vitro\u2013In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition","author":"Istanbullu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/00397911.2021.2010757","article-title":"Amino acid ionic liquid-catalyzed synthesis, anti-Leishmania activity, molecular docking, molecular dynamic simulation, and ADME study of 3, 4-dihydropyrimidin-2 (1 H)-(thio) ones","volume":"52","author":"Rode","year":"2022","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2023.115927_bib105","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/acsmedchemlett.2c00170","article-title":"Pyrimido [5, 4-d] pyrimidine-based compounds as a novel class of antitrypanosomal and antileishmanial agents","volume":"13","author":"Lopes","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115927_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112986","article-title":"Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2, 4-diaminopyrimidine-based analogues for the selective inhibition of L. major Dihydrofolate reductase","volume":"210","author":"Bibi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11686-021-00457-6","article-title":"Synthesis and biological evaluation of tetrahydropyrimidine and dihydropyridine derivatives against leishmania major","volume":"67","author":"Jeddi","year":"2022","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.ejmech.2023.115927_bib108","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3390\/molecules26082209","article-title":"Synthesis and evaluation of novel 2, 2-dimethylthiochromanones as anti-leishmanial agents","volume":"26","author":"Coll","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115927_bib109","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1007\/s11033-020-05887-5","article-title":"Investigation of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-chromen-2-one as a promising coumarin compound for the development of a new and orally effective antileishmanial agent","volume":"47","author":"de Figueiredo Peloso","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2023.115927_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03614","article-title":"Synthesis and evaluation of novel chromanone and quinolinone analogues of uniflorol as anti-leishmanial agents","volume":"6","author":"Castro","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2023.115927_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103787","article-title":"Synthesis of N-substituted indole derivatives as potential antimicrobial and antileishmanial agents","volume":"99","author":"Tiwari","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104816","article-title":"Novel coumarin-isatin hybrids as potent antileishmanial agents: synthesis, in silico and in vitro evaluations","volume":"110","author":"Khatoon","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108899","article-title":"Novel indol-3-yl-thiosemicarbazone derivatives: obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies","volume":"315","author":"da Silva","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115927_bib114","doi-asserted-by":"crossref","first-page":"14695","DOI":"10.1021\/acs.joc.2c02007","article-title":"One-pot cascade annulation-triggered synthesis of N-6-Substituted norcryptotackieine alkaloids and evaluation of their antileishmanial activities","volume":"87","author":"Majhi","year":"2022","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128289","article-title":"In vitro anti-Leishmania activity and molecular docking of spiro-acridine compounds as potential multitarget agents against Leishmania infantum","volume":"49","author":"Almeida","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115927_bib116","first-page":"127","article-title":"Antiprotozoal activity of xanthone derivatives, orbital","author":"Micheletti","year":"2020","journal-title":"Electron. J. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib117","first-page":"1","article-title":"Synthesis of new 3-acetyl-1, 3, 4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents","author":"Lachhab","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2023.115927_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259008","article-title":"Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity","volume":"16","author":"Clementino","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115927_bib119","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/pathogens11111339","article-title":"Design, synthesis, and antiprotozoal evaluation of new promising 2, 9-bis [(substituted-aminomethyl)]-4, 7-phenyl-1, 10-phenanthroline derivatives, a potential alternative scaffold to drug efflux","volume":"11","author":"Guillon","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2023.115927_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105414","article-title":"Novel phenanthridine amide analogs as potential anti-leishmanial agents: in vitro and in silico insights","volume":"117","author":"Nandikolla","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib121","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.3390\/molecules27217477","article-title":"Unveiling a new selenocyanate as a multitarget candidate with anticancer, antileishmanial and antibacterial potential","volume":"27","author":"Ramos-Inza","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115927_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111726","article-title":"Antileishmanial activity and insights into the mechanisms of action of symmetric Au (I) benzyl and aryl-N-heterocyclic carbenes","volume":"229","author":"Rosa","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2023.115927_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111385","article-title":"Development of new combination anti-leishmanial complexes: triphenyl Sb (V) mono-hydroxy mono-quinolinolates","volume":"219","author":"Duffin","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2023.115927_bib124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cbdd.13757","article-title":"Anticancer and antileishmanial in vitro activity of gold (I) complexes with 1, 3, 4\u2010oxadiazole\u20102 (3H)\u2010thione ligands derived from \u03b4\u2010D\u2010gluconolactone","volume":"97","author":"Espinosa","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115927_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114367","article-title":"Exploration of 6-methyl-7-(Hetero) Aryl-7-Deazapurine ribonucleosides as antileishmanial agents","volume":"237","author":"Lin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113101","article-title":"Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents","volume":"212","author":"Bouton","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib127","doi-asserted-by":"crossref","first-page":"92","DOI":"10.31080\/ASMI.2021.04.0916","article-title":"A review on the pharmacological importance of crimson passion flower (passiflora vitifolia: passifloraceae) - an endangered species","volume":"4","author":"Pal","year":"2021","journal-title":"Acta Scient. Microbio."},{"key":"10.1016\/j.ejmech.2023.115927_bib128","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2018.03.047","article-title":"A comprehensive review of chalcone derivatives as antileishmanial agents","volume":"150","author":"de Mello","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib129","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/antibiotics11101402","article-title":"Antileishmanial activity of 4, 8-dimethoxynaphthalenyl chalcones on leishmania amazonensis","volume":"11","author":"de Santiago-Silva","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2023.115927_bib130","article-title":"In vitro antileishmanial efficacy of antiplasmodial active aminoquinoline-chalcone hybrids","volume":"236","author":"Aucamp","year":"2022","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115927_bib131","first-page":"45","article-title":"Synthesis, characterization and pharmacological evaluation of chalcones and its derivatives for antileishmanial activity","author":"Nayak","year":"2022","journal-title":"J. Pharma. Res. Int."},{"key":"10.1016\/j.ejmech.2023.115927_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.103717","article-title":"Identification of some chalcone analogues as potential antileishmanial agents: an integrated in vitro and in silico evaluation","volume":"15","author":"Osman","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib133","first-page":"1","article-title":"Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compounds","author":"Hern\u00e1ndez-Rivera","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2023.115927_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.624678","article-title":"Identification of chalcone derivatives as inhibitors of Leishmania infantum arginase and promising antileishmanial agents","volume":"8","author":"Garcia","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.115927_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009951","article-title":"Chalcones identify cTXNPx as a potential antileishmanial drug target","volume":"15","author":"Escrivani","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115927_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183473","article-title":"Membrane dynamics in Leishmania amazonensis and antileishmanial activities of \u03b2-carboline derivatives","volume":"1863","author":"Alonso","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejmech.2023.115927_bib137","first-page":"1","article-title":"Design, synthesis and evaluation of novel \u03b2-carboline ester analogues as potential anti-leishmanial agents","author":"Karan Kumar","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115927_bib138","first-page":"1","article-title":"Synthesis, antileishmanial activity and molecular modeling of new 1-aryl\/alkyl-3-benzoyl\/cyclopropanoyl thiourea derivatives","author":"Mohammadi-Ghalehbin","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2023.115927_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109758","article-title":"Identification of potential antileishmanial 1, 3-disubstituted-4-hydroxy-6-methylpyridin-2 (1H)-ones, in vitro metabolic stability, cytotoxicity and molecular modeling studies","volume":"351","author":"Borkar","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115927_bib140","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/pathogens11091020","article-title":"In vitro and in silico analyses of new cinnamid and rosmarinic acid-derived compounds biosynthesized in Escherichia coli as leishmania amazonensis arginase inhibitors","volume":"11","author":"Come","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2023.115927_bib141","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dkab226","article-title":"An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis","volume":"76","author":"Pomel","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115927_bib142","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/open.202100159","article-title":"Design, synthesis and biological activity of C3 hemisynthetic triterpenic esters as novel antitrypanosomal hits","volume":"10","author":"Schioppa","year":"2021","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.ejmech.2023.115927_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105118","article-title":"Synthesis and comparison of in vitro dual anti-infective activities of novel naphthoquinone hybrids and atovaquone","volume":"114","author":"Erasmus","year":"2021","journal-title":"Bioorg. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423008942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423008942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:52:55Z","timestamp":1778676775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423008942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":143,"alternative-id":["S0223523423008942"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115927","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic product-based approach toward potential antileishmanial drug development","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115927"}}